Tallac Therapeutics
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $62M
Investors
- 5
About Tallac Therapeutics
Based in the US, Tallac Therapeutics, Inc.Tallac Therapeutics, Inc. was founded in 2018 in Burlingame, US. The company specializes in creating advanced antibody drug conjugates (ADCs) for oncology treatment. Hong Wan, the founder and current CEO, has previously established other ventures.Tallac Therapeutics, Inc. focuses on the development of antibody drug conjugates (ADCs) aimed at combating cancer. Their innovative pipeline includes oligonucleotide-based ADC candidates, particularly Toll-like Receptor Agonist Antibody Conjugates (TRAAC). These therapeutic agents are engineered to deliver potent Toll-like receptor (TLR9) agonists, specifically T-CpG, which activate the immune response in the tumor microenvironment. This technology enables precise conjugation of therapeutic oligonucleotide payloads, such as CpG oligonucleotides, antisense oligonucleotides, and siRNA, moving beyond traditional toxin payloads.Tallac Therapeutics operates through a partnership-based revenue model, focusing on collaborations with research institutions, healthcare organizations, and pharmaceutical companies involved in cancer treatment. The company's financial structure includes agreements for the development and commercialization of its TRAAC technology and related ADC products. The company aims to expand its presence in North America and Europe, focusing on regions with high demand for cancer therapies. Upcoming product launches are anticipated, although specific release dates have not been disclosed.
Who invested in Tallac Therapeutics
5 investors across 1 round
See all investors in Tallac Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2020
Amount
$62M
Investors
Questions about Tallac Therapeutics
Who invested in Tallac Therapeutics?
Tallac Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tallac Therapeutics raised?
Tallac Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tallac Therapeutics last raise money?
Tallac Therapeutics's most recent round on record is a Series A, in Dec 2020.
What does Tallac Therapeutics do?
Based in the US, Tallac Therapeutics, Inc.
Where is Tallac Therapeutics headquartered?
Tallac Therapeutics is headquartered in Burlingame, US.
Which VCs invest in companies like Tallac Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tallac Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tallac Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.